HIMALAIA (Hypertension Induction in the Management of AneurysmaL subArachnoid haemorrhage with secondary IschaemiA): a randomized single-blind controlled trial of induced hypertension vs. no induced hypertension in the treatment of delayed cerebral ischemia after subarachnoid hemorrhage.

C S Gathier; W M van den Bergh; A J C Slooter

首页> 外文期刊>International journal of stroke: official journal of the International Stroke Society >HIMALAIA (Hypertension Induction in the Management of AneurysmaL subArachnoid haemorrhage with secondary IschaemiA): a randomized single-blind controlled trial of induced hypertension vs. no induced hypertension in the treatment of delayed cerebral ischemia after subarachnoid hemorrhage.

【24h】

HIMALAIA (Hypertension Induction in the Management of AneurysmaL subArachnoid haemorrhage with secondary IschaemiA): a randomized single-blind controlled trial of induced hypertension vs. no induced hypertension in the treatment of delayed cerebral ischemia after subarachnoid hemorrhage.

机译：HIMALAIA（在继发IschaemiA的动脉瘤亚蛛网膜下腔出血管理中诱导高血压）：一项随机性单盲对照试验，在蛛网膜下腔出血后迟发性脑缺血的治疗中诱发高血压与不诱发高血压。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The primary outcome is the proportion of subarachnoid hemorrhage patients with delayed cerebral ischemia with poor outcome three-months after randomization, defined as a modified Rankin scale of more than 3. Secondary outcome measures are related to treatment failure, functional outcome, adverse events, and cerebral hemodynamics. The HIMALAIA trial is registered at clinicaltrials.gov under identifier NCT01613235.

机译：主要结局指标是随机化后三个月，蛛网膜下腔出血伴有脑缺血延迟且结局较差的患者的比例，定义为改良的Rankin量表大于3。次要结局指标与治疗失败，功能结局，不良事件和脑血流动力学。 HIMALAIA试验已在Clinicaltrials.gov上注册，标识为NCT01613235。

著录项

来源
《International journal of stroke: official journal of the International Stroke Society》 |2014年第3期|共6页
作者
C S Gathier; W M van den Bergh; A J C Slooter;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学与精神病学;
关键词

相似文献

外文文献
中文文献
专利

1. HIMALAIA (Hypertension Induction in the Management of AneurysmaL subArachnoid haemorrhage with secondary IschaemiA): a randomized single-blind controlled trial of induced hypertension vs. no induced hypertension in the treatment of delayed cerebral ischemia after subarachnoid hemorrhage. [J] . C S Gathier, W M van den Bergh, A J C Slooter International journal of stroke: official journal of the International Stroke Society . 2014,第3期

机译：HIMALAIA（在继发IschaemiA的动脉瘤亚蛛网膜下腔出血管理中诱导高血压）：一项随机性单盲对照试验，在蛛网膜下腔出血后迟发性脑缺血的治疗中诱发高血压与不诱发高血压。
2. Effects of Induced Hypertension on Cerebral Perfusion in Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage A Randomized Clinical Trial [J] . Gathier Celine S., Dankbaar Jan Willem, van der Jagt Mathieu, Stroke: A Journal of Cerebral Circulation . 2015,第11期

机译：诱发高血压对延迟性脑缺血后蛛网膜下腔出血后脑灌注的影响随机临床试验
3. Induced Hypertension for Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage A Randomized Clinical Trial [J] . Gathier Celine S., van den Bergh Walter M., van der Jagt Mathieu, Stroke: A Journal of Cerebral Circulation . 2018,第1期

机译：动脉瘤蛛网膜下腔出血后随机临床试验诱导脑缺血的高血压
4. Adding Potassium and Calcium to the dietary salt as a hypertension-preventive approach in adolescents with higher blood pressure and their family members: a random single-blind controlled trial [C] . Jianjun Mu, Zhiquan Liu, Xianglin Xu, “中、美食盐与健康”国际研讨会（International Workshop of Dietary Sodium and Human Health in China and the United States） . 2008

机译：在高血压的青少年及其家庭成员中，作为预防高血压的方法，向饮食盐中添加钾和钙：一项随机的单盲对照试验
5. The effects of induced hypertension on cerebral perfusion during delayed cerebral ischaemia in aneurysmal subarachnoid haemorrhage: a randomised clinical trial [O] . CS Gathier, JW Dankbaar, M Van der Jagt, 2015

机译：诱发性高血压对动脉瘤性蛛网膜下腔出血延迟脑缺血期间脑灌注的影响：一项随机临床试验
6. THE EFFECTS OF INDUCED HYPERTENSION ON CEREBRAL PERFUSION DURING DELAYED CEREBRAL ISCHAEMIA IN ANEURYSMAL SUBARACHNOID HAEMORRHAGE: A RANDOMISED CLINICAL TRIAL [O] . CS Gathier, JW Dankbaar, M Van der Jagt, 2015

机译：诱导的高血压对迟发性蛛网膜下腔出血患者脑缺血过程中脑灌注的影响：一项随机临床试验
7. Brief Episode of Severe Arterial Hypertension Induces Delayed Deterioration of Brain Function and Worsens Blood Flow after Transient Multifocal Cerebral Ischemia [R] . Dutka, A. J., Hallenbeck, J. M., Kochanek, P. 1987

机译：严重动脉高压短暂发作引起暂时性多灶性脑缺血后脑功能迟发性恶化和血流恶化

HIMALAIA (Hypertension Induction in the Management of AneurysmaL subArachnoid haemorrhage with secondary IschaemiA): a randomized single-blind controlled trial of induced hypertension vs. no induced hypertension in the treatment of delayed cerebral ischemia after subarachnoid hemorrhage.

摘要

著录项

相似文献

相关主题

期刊订阅